|When:||« Back to Calendar January 30, 2018 @ 12:00 pm - 1:00 pm|
|Add to Calendar Add to Google Cal|
New regulatory requirements and relationships with payers are requiring medical device companies to collect and share data earlier in the device development cycle than ever before. Additionally, trial data alone may not be sufficient for real market access. Post marketing research and device monitoring are also requiring planning and use of data collection and analytics capabilities. This webinar will talk briefly about the stakeholders in device trials, market access and post marketing device monitoring. We’ll also discuss new models for trials and post market secure collection of data and providing access to device companies, patients, healthcare teams and payers.
Mark Vermette, Principal Consultant, Halloran Consulting Group
Mark is the lead for solutions consulting at Halloran. Halloran helps customers navigate to leadership positions in drug and device development. Mark and his team guide customers with technology strategies to fit their business models and goals.
Dr. Kyle E. Dolbow, CEO, HealthFactors
Kyle was a founder of Preventice, a company focused on remote cardiac monitoring and integration into care management. He also served as President of Vree Health, an innovative subsidiary of Merck, which focuses on technology-enabled care management services. HealthFactors digital health services enable medical device companies to more effectively engage their patients, improve their understanding of patient behaviors, and partner more closely with providers and payers.
After registering, you will receive a confirmation email containing information about joining the webinar.